Williams, Timothy K <br/><br/>
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.  [electronic resource] 

 -  PloS one  Nov 2010 
 - e15455 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0015455  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Surface--genetics<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Deoxycytidine--analogs & derivatives<br/>Deoxycytidine Kinase--genetics<br/>Drug Resistance--genetics<br/>ELAV Proteins<br/>ELAV-Like Protein 1<br/>HEK293 Cells<br/>Humans<br/>Pancreatic Neoplasms--genetics<br/>Protein Binding<br/>RNA Interference<br/>RNA, Messenger--genetics<br/>RNA-Binding Proteins--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Gemcitabine